China, Sept. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Construction of a Multimodal Central-Peripheral Physiological Signal Dataset for Post-S... Read More
China, Sept. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'CGF-Assisted Periodontal Regenerative Surgery in the Treatment of Periodontal-Endodonti... Read More
China, Sept. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Study on the Development and Application of a Decision Support System for PICC Line P... Read More
China, Sept. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study on the Effects of Aniseikonic Correction Lenses on Binocular Visual Function and ... Read More
China, Sept. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical Phenotypes and Molecular Characteristics of Nephropathy Associated with Homozy... Read More
China, Sept. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Development and Effectiveness Study of a Smart Frailty Management Model for Older Adult... Read More
China, Sept. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled '[89Zr]Y08-Larm PET/CT Imaging for Evaluating the FGFR2b Target in Gastric Cancer'. The ... Read More
China, Sept. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Impact of prophylactic pancreatic and biliary stenting on complications following endos... Read More
China, Sept. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Effect of Valproic Acid Serum Concentration on Survival in Patients with Glioma-Associa... Read More
China, Sept. 7 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Efficacy and Safety of Iparomlimab and Tuvonralimab Combined With Capecitabine Chemothe... Read More